中性粒细胞脱颗粒内容物对肿瘤发生发展影响的研究进展*

马文艳, 龚倩, 张百红, 董开忠

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (3) : 379 -383.

PDF (1008KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (3) : 379 -383. DOI: 10.3969/j.issn.1674-7593.2026.03.019
综述

中性粒细胞脱颗粒内容物对肿瘤发生发展影响的研究进展*

    马文艳1,3, 龚倩2,3, 张百红3**, 董开忠1
作者信息 +

Research progress in understanding the role of neutrophil degranulation products in tumor initiation and progression

    Ma Wenyan1,3, Gong Qian2,3, Zhang Baihong3**, Dong Kaizhong1
Author information +
文章历史 +
PDF (1031K)

摘要

中性粒细胞是组成人体固有免疫系统的重要组成成分,参与机体抵抗病原体入侵过程。中性粒细胞脱颗粒产生多种具有生物活性的颗粒内容物,作用于肿瘤微环境,影响肿瘤细胞的发生、发展及转移。该文对中性粒细胞脱颗粒的颗粒内容物介导的肿瘤微环境对于肿瘤的多效作用作一综述,探究其在肿瘤免疫治疗中可能的应用价值。

Abstract

Neutrophils are a crucial element of the human innate immune system, contributing to the body's defense against pathogen invasion. Neutrophils undergo degranulation, releasing diverse bioactive granule contents that affect the tumor microenvironment, ultimately impacting the start, development, and metastasis of tumor cells. This article reviews the pleiotropic effects of the tumor microenvironment mediated by granule contents released during neutrophil degranulation on tumors and examines their possible applicability in tumor immunotherapy.

关键词

中性粒细胞脱颗粒 / 颗粒内容物 / 肿瘤微环境 / 免疫治疗

Key words

Neutrophil degranulation / Particle contents / Tumor microenvironment / Immunotherapy

引用本文

引用格式 ▾
马文艳, 龚倩, 张百红, 董开忠. 中性粒细胞脱颗粒内容物对肿瘤发生发展影响的研究进展*[J]. 国际老年医学杂志, 2026, 47(3): 379-383 DOI:10.3969/j.issn.1674-7593.2026.03.019

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1] Faget J, Peters S, Quantin X, et al. Neutrophils in the era of immune checkpoint blockade[J]. J Immunother Cancer, 2021, 9(7): e002242.
[2] Ma Y, Yabluchanskiy A, Lindsey M L. Neutrophil roles in left ventricular remodeling following myocardial infarction[J]. Fibrogenesis Tissue Repair, 2013, 6(1): 11.
[3] Amulic B, Cazalet C, Hayes G L, et al. Neutrophil function: from mechanisms to disease[J]. Annu Rev Immunol, 2012, 30: 459-489.
[4] Cowland J B, Borregaard N. Granulopoiesis and granules of human neutrophils[J]. Immunol Rev, 2016, 273(1): 11-28.
[5] Ballesteros I, Hidalgo A. The neutrophil collective[J]. Cell, 2025, 188(25): 7019-7035.
[6]Rizo-Téllez S A, Sekheri M, Filep J G. Myeloperoxidase: regulation of neutrophil function and target for therapy[J]. Antioxidants, 2022, 11(11): 2302.
[7] Lin W, Chen H, Chen X, et al. The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress[J]. Antioxidants, 2024, 13(1): 132.
[8] Coussens L M, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[9] Jannesar K, Soraya H. MPO and its role in cancer, cardiovascular and neurological disorders: an update[J]. Biochem Biophys Res Commun, 2025, 755: 151578.
[10] Yazdani H O, Roy E, Comerci A J, et al. Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth[J]. Cancer Res, 2019, 79(21): 5626-5639.
[11] Karimi E, Yu M W, Maritan S M, et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours[J]. Nature, 2023, 614(7948): 555-563.
[12] Huang H, Zhang H, Onuma A E, et al. Neutrophil elastase and neutrophil extracellular traps in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1263: 13-23.
[13] Houghton A M, Rzymkiewicz D M, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth[J]. Nat Med, 2010, 16(2): 219-223.
[14] Castaño M, Tomás-Pérez S, González-Cantó E, et al. Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian cancer[J]. Int J Mol Sci, 2023, 24(6): 5995.
[15] Piotrowski I, Kulcenty K, Suchorska W. Interplay between inflammation and cancer[J]. Rep Pract Oncol Radiother, 2020, 25(3): 422-427.
[16] 魏秀珍, 张政杰, 谭勇, 等. 胃癌转移相关因子的研究进展[J]. 国际老年医学杂志, 2024, 45(2): 234-237.
Wei X Z, Zhang Z J, Tan Y, et al. Research progress of metastasis related factors in gastric cancer[J]. Int J Geriatr, 2024, 45(2): 234-237.
[17] Jia W, Luo Q, Wu J, et al. Neutrophil elastase as a potential biomarker related to the prognosis of gastric cancer and immune cell infiltration in the tumor immune microenvironment[J]. Sci Rep, 2023, 13(1): 13447.
[18] Jia W, Mao Y, Luo Q, et al. Targeting neutrophil elastase is a promising direction for future cancer treatment[J]. Discov Oncol, 2024, 15(1): 167.
[19] Zeng W, Song Y, Wang R, et al. Neutrophil elastase: from mechanisms to therapeutic potential[J]. J Pharm Anal, 2023, 13(4): 355-366.
[20] Albrengues J, Shields M A, Ng D, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice[J]. Science, 2018, 361(6409): eaao4227.
[21] Kai F, Drain A P, Weaver V M. The extracellular matrix modulates the metastatic journey[J]. Dev Cell, 2019, 49(3): 332-346.
[22] Zeng Y, Gao M, Lin D, et al. Prognostic and immunological roles of MMP-9 in pan-cancer[J]. Biomed Res Int, 2022, 2022: 2592962.
[23] Cai N, Cheng K, Ma Y, et al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy[J]. Gut, 2024, 73(6): 985-999.
[24] Shoari A, Ashja Ardalan A, Dimesa A M, et al. Targeting invasion: the role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy[J]. Biomolecules, 2024, 15(1): 35.
[25] Juric V, O'sullivan C, Stefanutti E, et al. MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors[J]. PLoS One, 2018, 13(11): e0207255.
[26] Huang G Z, Wu Q Q, Zheng Z N, et al. Bioinformatics analyses indicate that cathepsin G (CTSG) is a potential immune-related biomarker in oral squamous cell carcinoma (OSCC)[J]. Onco Targets Ther, 2021, 14: 1275-1289.
[27] Dai Q, Yao X, Zhang Y, et al. CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer[J]. J Cancer Res Clin Oncol, 2024, 151(1): 21.
[28] Lin M, Jackson P, Tester A M, et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro[J]. Am J Pathol, 2008, 173(1): 144-153.
[29] Wu Y, Liu H, Sun Z, et al. The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects[J]. Cell Death Dis, 2024, 15(6): 455.
[30] Gutiérrez-Fernández A, Fueyo A, Folgueras A R, et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion[J]. Cancer Res, 2008, 68(8): 2755-2763.
[31] Juurikka K, Dufour A, Pehkonen K, et al. MMP8 increases tongue carcinoma cell-cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5[J]. Oncogenesis, 2021, 10(5): 44.
[32] Juurikka K, Butler G S, Salo T, et al. The role of MMP8 in cancer: a systematic review[J]. Int J Mol Sci, 2019, 20(18): 4506.
[33] Jiang Y, Li X, Yang Y, et al. LncRNA HOXC-AS1 sponges miR-99a-3p and upregulates MMP8, ultimately promoting gastric cancer[J]. Cancers, 2022, 14(14): 3534.

基金资助

*甘肃省自然科学基金项目(22JR5RA007)

AI Summary AI Mindmap
PDF (1008KB)

72

访问

0

被引

详细

导航
相关文章

AI思维导图

/